“清晰”是什么意思?
该动物不携带突变。就不会发展成这种疾病 并且不会将其传递下去。
Afibrinogenaemia in dogs is a rare but serious genetic disorder affecting blood clotting. A DNA test for afibrinogenaemia can help identify carriers and affected dogs, ensuring early diagnosis and management. Symptoms may include excessive bleeding, prolonged recovery from injuries, and spontaneous hemorrhages. By understanding the genetic basis of this condition, breeders can make informed decisions to prevent its occurrence in future litters. If you suspect your dog may have afibrinogenaemia, consult your veterinarian for testing options. Early intervention can significantly improve your dog's quality of life. Protect your furry friend by considering a DNA test today!
Afibrinogenaemia is a rare genetic disorder in dogs characterized by the absence of fibrinogen, a crucial protein for blood clotting. A DNA test can identify carriers and affected dogs, helping breeders make informed decisions to prevent the condition. Symptoms often include excessive bleeding, easy bruising, and prolonged wound healing. Early diagnosis through genetic testing is vital for managing the health of affected dogs. Understanding this condition allows for better care and improves the quality of life for these pets.
我们的包装中已包含此 DNA 测试 Basic — 也是包的一部分 Basic, Standard, Advanced, Complete。
查看 DNA 测试包 →Afibrinogenaemia is a rare genetic disorder characterized by the absence of fibrinogen, a crucial protein involved in the blood coagulation process. This condition can lead to severe bleeding episodes, making it a significant health concern for affected dogs. The lack of fibrinogen impairs the body's ability to form blood clots, which is essential for stopping bleeding following an injury or during surgical procedures.
The condition is caused by mutations in the FGA gene, which is responsible for producing fibrinogen. These mutations can lead to a complete absence of fibrinogen in the blood, resulting in the clinical manifestation of afibrinogenaemia. The genetic nature of this disorder means that it can be inherited, and identifying carriers of the mutation is crucial for breeding decisions to prevent the propagation of this trait.
Dogs with afibrinogenaemia may present with various clinical signs, primarily related to bleeding. Common symptoms include spontaneous bruising, prolonged bleeding from minor wounds, and excessive bleeding during or after surgical procedures. Some dogs may also experience internal bleeding, which can manifest as weakness, lethargy, or an increased heart rate. It's essential for pet owners to recognize these signs and seek veterinary attention promptly.
Diagnosis typically involves a combination of clinical evaluation and laboratory tests. Blood tests can reveal low or absent levels of fibrinogen, and additional coagulation studies may be performed to assess the overall clotting ability of the blood. In some cases, a DNA test can confirm the presence of mutations associated with afibrinogenaemia, providing a definitive diagnosis.
While there is no cure for afibrinogenaemia, management focuses on preventing and controlling bleeding episodes. This may include the use of blood transfusions to provide necessary clotting factors during emergencies. Additionally, veterinarians may recommend avoiding procedures that could lead to bleeding and closely monitoring affected dogs for any signs of bleeding. In some cases, supportive care and medication may be employed to manage symptoms and improve the dog's quality of life.
Genetic testing plays a crucial role in the management of afibrinogenaemia. By identifying carriers of the mutation, breeders can make informed decisions to minimize the risk of producing affected offspring. Early identification of at-risk dogs allows for proactive management strategies, improving outcomes for affected individuals and enhancing overall breed health.
Afibrinogenaemia is a serious inherited bleeding disorder in dogs that requires careful management and awareness. Understanding the genetic basis, clinical signs, and treatment options is vital for pet owners and veterinarians alike. Through genetic testing and responsible breeding practices, the incidence of this condition can be reduced, promoting healthier futures for dogs at risk.
该动物不携带突变。就不会发展成这种疾病 并且不会将其传递下去。
不会。该动物通常是健康的,但可以将突变传播给它的 后代。
它携带两个突变的副本。预计临床症状取决于 这种疾病。它不应该被培育。
有些疾病与性别相关,因此其表现因性别而异 动物的性别。
This DNA test detects the mutation associated with Afibrinogenaemia in order to identify clear, carrier, or at-risk animals.
DNA 测试有助于饲养员计划更安全的交配并降低将突变传播给后代的风险。
该测试报告的遗传模式是常染色体隐性遗传。
This test analyses the mutation FGA c.1665delT.
未必。解释取决于遗传模式和产生的基因型。
Mischke Reinhard, Metzger Julia, Distl Ottmar. An FGA Frameshift Variant Associated with Afibrinogenemia in Dachshunds. Genes (Basel). 2021 Jul 13;12(7):1065. doi: 10.3390/genes12071065.